Selatogrel is a
P2Y12 inhibitor that has been proposed as a treatment for
acute myocardial infarction
A myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops in one of the coronary arteries of the heart, causing infarction (tissue death) to the heart muscle. The most common symptom is retr ...
.
References
Experimental drugs
Aminopyrimidines
Pyrrolidines
Piperazines
Carbamates
Phosphonic acids
Butyl esters
{{cardiovascular-drug-stub